Daily as of 3 Nov 16:00 ET
- Price
- below both $26.99 vs 50 $27.21 / 200 $30.89
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 7 Jul 2026 · projected 25 bars out · tested 3 bars
STOK | Stoke TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$26.99
+$0.51 (+1.93%)
Stoke Therapeutics (STOK) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat below the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $26.29 vs 50 $30.89 / 200 $16.06
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 15 Sep 2025 · projected 23 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $26.99 vs 50 $25.27 / 200 $29.08
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 17 Sep 2026 · projected 28 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 17 Sep 2026 | 💀Death | 4-hour | 28 bars out | Not tested |
| 31 Aug 2026 | 🟨Golden | 4-hour | 19 bars out | 2 bar cross test |
| 7 Jul 2026 | 💀Death moderate | daily | 25 bars out | 3 bar cross test |
| 21 May 2026 | 💀Death | 4-hour | 23 bars out | Not tested |
| week of 15 Sep 2025 | 🟨Golden flat | weekly | 23 bars out | Not tested |
About STOK
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$24.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandsmall